Effect Of Nintedanib On Pro-Fibrotic And Anti-Fibrotic Cytokine Release From Alveolar Macrophages In Interstitial Lung Diseases

被引：0
|
作者：
Bonella, F. [1 ]
Long, X. [1 ]
He, X. [1 ]
Theegarten, D. [2 ]
Wessendorf, T. E. [1 ]
Guzman, J. [3 ]
Costabel, U. [1 ]
机构：
[1] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany
[2] Univ Duisburg Essen, Uniklinikum Essen, Essen, Germany
[3] Ruhr Univ, Bochum, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3151
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ENDOTHELIAL FENESTRATION OF THE ALVEOLAR CAPILLARIES IN INTERSTITIAL FIBROTIC LUNG-DISEASES
    KAWANAMI, O
    MATSUDA, K
    YONEYAMA, H
    FERRANS, VJ
    CRYSTAL, RG
    ACTA PATHOLOGICA JAPONICA, 1992, 42 (03): : 177 - 184
  • [32] Hypoxia Exacerbates Lung Fibrosis And Promotes Pro-Fibrotic Responses In Alveolar Epithelial Cells
    Burman, A.
    Lawson, W. E.
    Blackwell, T. S.
    Tanjore, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [33] Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: A potential risk to individuals with impaired kidney function
    Liu, Shuyun
    Zhao, Meng
    Zhou, Yijie
    Wang, Chengshi
    Yuan, Yujia
    Li, Lan
    Bresette, William
    Chen, Younan
    Cheng, Jingqiu
    Lu, Yanrong
    Liu, Jingping
    PHYTOMEDICINE, 2019, 57 : 223 - 235
  • [34] Pro-fibrotic and anti-fibrotic gene expression in sequential protocol biopsies from renal transplant recipients who develop chronic allograft nephropathy.
    Mengel, Michael
    Priess, Maren
    Schwarz, Anke
    Haller, Hermann
    Kreipe, Hans
    Bock, Oliver
    Gwinner, Wilfried
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 181 - 181
  • [35] IL10 Polarizes Lung Monocyte Derived Macrophages to a Pro-Fibrotic Phenotype
    Bhattacharyya, A.
    Boostanpour, K.
    Bouzidi, M.
    Magee, L.
    Chen, T.
    Wolters, R.
    Torre, P.
    Pillai, S.
    Bhattacharya, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [36] Nintedanib: A Review in Fibrotic Interstitial Lung Diseases (vol 81, pg 575, 2021)
    Lamb, Yvette N.
    DRUGS, 2021, 81 (09) : 1133 - 1133
  • [37] Anti-fibrotic effect of meloxicam in a murine lung fibrosis model
    Arafa, Hossam M. M.
    Abdel-Wahab, Mohamed H.
    El-Shafeey, Mohamed F.
    Badary, Osama A.
    Hamada, Farid M. A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 564 (1-3) : 181 - 189
  • [38] Therapeutic Anti-Fibrotic Effect of Nintedanib in a Rat Model of Lung Fibrosis Induced by a Double Bleomycin Intratracheal Administration
    Pitozzi, V.
    Caruso, P.
    Pontis, S.
    Pittelli, M.
    Bonatti, M.
    Frati, C.
    Madeddu, D.
    Quaini, F.
    Lagrasta, C.
    Villetti, G.
    Civelli, M.
    Trevisani, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [39] Increase in Myocardial Pro-Fibrotic Genes with LVAD and Potential Anti-fibrotic Properties of a Novel Peptide CD-NP in Human Cardiac Fibroblasts
    Ichiki, Tomoko
    Schirger, John A.
    Brozobich, Frank C.
    Huntley, Brenda K.
    Sangaralingham, S. Jeson
    Mckie, Paul A.
    Park, Soon J.
    Burnett, John C.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S144 - S144
  • [40] Impact of an interstitial lung diseases Nurse on the compliance to anti-fibrotic drugs in patients with Idiopathic Pulmonary Fibrosis.
    Mendoza, Onofre Moran
    Aldhaheri, Sharina
    Mccarthy, Lynda
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345